Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 7
2022 15
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.
Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M, Hushmandi K, Sethi G, Zarrabi A, Kumar AP, Tan SC, Papadakis M, Alexiou A, Islam MA, Mostafavi E, Ashrafizadeh M. Paskeh MDA, et al. J Hematol Oncol. 2022 Jun 28;15(1):83. doi: 10.1186/s13045-022-01305-4. J Hematol Oncol. 2022. PMID: 35765040 Free PMC article. Review.
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives.
Zandieh MA, Farahani MH, Rajabi R, Avval ST, Karimi K, Rahmanian P, Razzazan M, Javanshir S, Mirzaei S, Paskeh MDA, Salimimoghadam S, Hushmandi K, Taheriazam A, Pandey V, Hashemi M. Zandieh MA, et al. Among authors: paskeh mda. Pharmacol Res. 2023 Jan;187:106582. doi: 10.1016/j.phrs.2022.106582. Epub 2022 Nov 24. Pharmacol Res. 2023. PMID: 36436707 Free article. Review.
Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
Hashemi M, Aparviz R, Beickzade M, Paskeh MDA, Kheirabad SK, Koohpar ZK, Moravej A, Dehghani H, Saebfar H, Zandieh MA, Salimimoghadam S, Rashidi M, Taheriazam A, Entezari M, Samarghandian S. Hashemi M, et al. Among authors: paskeh mda. Biomed Pharmacother. 2023 Dec 31;169:115927. doi: 10.1016/j.biopha.2023.115927. Epub 2023 Nov 24. Biomed Pharmacother. 2023. PMID: 38006616 Free article. Review.
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions.
Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. Sadrkhanloo M, et al. Among authors: paskeh mda. Biomed Pharmacother. 2023 Feb;158:114168. doi: 10.1016/j.biopha.2022.114168. Epub 2023 Jan 3. Biomed Pharmacother. 2023. PMID: 36916439 Free article. Review.
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Paskeh MDA, et al. Pharmacol Res. 2023 Jan;187:106553. doi: 10.1016/j.phrs.2022.106553. Epub 2022 Nov 15. Pharmacol Res. 2023. PMID: 36400343 Free article. Review.
EZH2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M, Nazdari N, Gholamiyan G, Paskeh MDA, Jafari AM, Nemati F, Khodaei E, Abyari G, Behdadfar N, Raei B, Raesi R, Nabavi N, Hu P, Rashidi M, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: paskeh mda. Pathol Res Pract. 2024 Jan;253:154988. doi: 10.1016/j.prp.2023.154988. Epub 2023 Nov 29. Pathol Res Pract. 2024. PMID: 38118215 Review.
Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response.
Hashemi M, Paskeh MDA, Orouei S, Abbasi P, Khorrami R, Dehghanpour A, Esmaeili N, Ghahremanzade A, Zandieh MA, Peymani M, Salimimoghadam S, Rashidi M, Taheriazam A, Entezari M, Hushmandi K. Hashemi M, et al. Among authors: paskeh mda. Biomed Pharmacother. 2023 May;161:114546. doi: 10.1016/j.biopha.2023.114546. Epub 2023 Mar 21. Biomed Pharmacother. 2023. PMID: 36958191 Free article. Review.
miRNAs as short non-coding RNAs in regulating doxorubicin resistance.
Mirzaei S, Paskeh MDA, Moghadam FA, Entezari M, Koohpar ZK, Hejazi ES, Rezaei S, Kakavand A, Aboutalebi M, Zandieh MA, Rajabi R, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S. Mirzaei S, et al. Among authors: paskeh mda. J Cell Commun Signal. 2023 Dec;17(4):1181-1202. doi: 10.1007/s12079-023-00789-0. Epub 2023 Nov 29. J Cell Commun Signal. 2023. PMID: 38019354 Free PMC article. Review.
siRNA and targeted delivery systems in breast cancer therapy.
Mirzaei S, Paskeh MDA, Entezari M, Bidooki SH, Ghaleh VJ, Rezaei S, Hejazi ES, Kakavand A, Behroozaghdam M, Movafagh A, Taheriazam A, Hashemi M, Samarghandian S. Mirzaei S, et al. Among authors: paskeh mda. Clin Transl Oncol. 2023 May;25(5):1167-1188. doi: 10.1007/s12094-022-03043-y. Epub 2022 Dec 23. Clin Transl Oncol. 2023. PMID: 36562927 Review.
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis.
Taheriazam A, Abad GGY, Hajimazdarany S, Imani MH, Ziaolhagh S, Zandieh MA, Bayanzadeh SD, Mirzaei S, Hamblin MR, Entezari M, Aref AR, Zarrabi A, Ertas YN, Ren J, Rajabi R, Paskeh MDA, Hashemi M, Hushmandi K. Taheriazam A, et al. Among authors: paskeh mda. J Control Release. 2023 Feb;354:503-522. doi: 10.1016/j.jconrel.2023.01.028. Epub 2023 Jan 19. J Control Release. 2023. PMID: 36641122 Review.
33 results